This information was published on 2025-03-24T08:18:54 for IP Right Registration Published.
| Field | Value |
| (210) | 2394006 (IR 1754084) |
| (220) |
16 Aug 2023
|
| (300) |
US, 17 Feb 2023, 97799503
|
| (500) |
The mark consists of the text "allo" above the text "vir" with the "o" in "allo" vertically aligned with the "v" in "vir"; the "o" in "allo" is partially surrounded by an arch bisected by a circle above which is a smaller arch partially surrounding the circle. The color gray is intended to show shading or contrast only.
It is a condition of registration that any use in respect of pharmaceuticals will be limited to such goods containing substances belonging to the pharmacological group designated by the International Non-Proprietary Name stem -VIR. It is a condition of protection that any use in respect of pharmaceuticals will be limited to such goods containing substances belonging to the pharmacological group designated by the International Non-Property Name stem -VIR |
| (511) (510) |
Class 5
Cell therapy products; cell therapy products for restoration and enhancement of patients' immune systems, allogeneic cell therapy products; cells for medical use; cellular function activating agents for medical purposes; immunotherapeutic agents. Class 42 Research and development in the pharmaceutical and biotechnology fields. |
| (540) |
|
| (550) | Figurative |
| (730) |
Allovir, Inc.
|
| (750) |
Davies Collison Cave Pty Ltd
|
Find out more about publications on the About page.